We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$851B
AUM Growth
+$80.9B
Cap. Flow
+$19.9B
Cap. Flow %
2.34%
Top 10 Hldgs %
25.93%
Holding
4,889
New
83
Increased
3,362
Reduced
611
Closed
132

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.18B
2
AAPL icon
Apple
AAPL
+$1.11B
3
AVGO icon
Broadcom
AVGO
+$562M
4
AMZN icon
Amazon
AMZN
+$553M
5
PANW icon
Palo Alto Networks
PANW
+$485M

Sector Composition

Rank Sector Weight
1 Technology 28.24%
2 Healthcare 13.33%
3 Financials 12.09%
4 Consumer Discretionary 10.85%
5 Industrials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATNX
4876
DELISTED
Athenex, Inc. Common Stock
ATNX
-27,540
Closed -$36.6K
LCI
4877
DELISTED
Lannett Company, Inc.
LCI
-85,034
Closed -$148K
CHRA
4878
DELISTED
Charah Solutions, Inc Common Stock
CHRA
-15,485
Closed -$32.4K
NH
4879
DELISTED
NantHealth, Inc
NH
-27,150
Closed -$54.4K
SRGA
4880
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
-44,698
Closed -$71.5K
PTE
4881
DELISTED
PolarityTE, Inc. Common Stock
PTE
-31,241
Closed -$15K
ONCS
4882
DELISTED
OncoSec Medical Incorporated
ONCS
-10,512
Closed -$27.1K
CTIC
4883
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-2,029,780
Closed -$8.53M
HSKA
4884
DELISTED
Heska Corp
HSKA
-193,387
Closed -$18.9M
CEMI
4885
DELISTED
Chembio diagnostics, Inc.
CEMI
-279,456
Closed -$124K
OZON
4886
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
-73,245
Closed -$154K
IMH
4887
DELISTED
Impac Mortgage Holdings Inc.
IMH
-88,453
Closed -$31K
HHR
4888
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
-28,935
Closed -$78.8K
FIEE
4889
FiEE Inc
FIEE
$25.1M
-648
Closed -$1.76K

Similar funds

Geode Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Geode Capital Management held 4,889 positions worth $851B, up 11% from $770B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4.4%. Geode Capital Management opened 83 new positions and exited 132, leaving the 4,889-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2023 buy was Coupang: 4,567,454 shares worth $79.5M.
  • Geode Capital Management added most to Microsoft in Q2 2023, an estimated $1.18B increase.
  • Geode Capital Management's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $246M.
  • Geode Capital Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
  • Geode Capital Management's ten largest holdings make up 26% of its $851B portfolio in Q2 2023.
  • Geode Capital Management opened 83 new positions and closed 132 in Q2 2023.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $851B.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.